Trial ID or NCT#

NCT02652949

Status

recruiting iconRECRUITING

Purpose

The purpose of the Valiant Evo US Clinical Trial is to demonstrate the safety and effectiveness of the Valiant Evo Thoracic Stent Graft System in subjects with a descending thoracic aortic aneurysm (DTAA) who are candidates for endovascular repair.

Official Title

Valiant Evo US Clinical Trial

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Jason T. Lee, MD
Jason T. Lee, MD
Vascular surgeon
Professor of Surgery (Vascular Surgery)

Contact us to find out if this trial is right for you.

CONTACT

Steven Cavella